PT938900E - Profilaticos/medicamentos para estomatite - Google Patents

Profilaticos/medicamentos para estomatite

Info

Publication number
PT938900E
PT938900E PT97928459T PT97928459T PT938900E PT 938900 E PT938900 E PT 938900E PT 97928459 T PT97928459 T PT 97928459T PT 97928459 T PT97928459 T PT 97928459T PT 938900 E PT938900 E PT 938900E
Authority
PT
Portugal
Prior art keywords
stomatitis
prophylatics
medications
zinc
remeties
Prior art date
Application number
PT97928459T
Other languages
English (en)
Inventor
Hirano Masaaki
Katayama Shiro
Original Assignee
Hamari Chemicals Ltd
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamari Chemicals Ltd, Zeria Pharm Co Ltd filed Critical Hamari Chemicals Ltd
Publication of PT938900E publication Critical patent/PT938900E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
PT97928459T 1996-07-03 1997-06-25 Profilaticos/medicamentos para estomatite PT938900E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19164096A JP3877807B2 (ja) 1996-07-03 1996-07-03 口内炎治療・予防剤

Publications (1)

Publication Number Publication Date
PT938900E true PT938900E (pt) 2006-07-31

Family

ID=16278026

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97928459T PT938900E (pt) 1996-07-03 1997-06-25 Profilaticos/medicamentos para estomatite

Country Status (11)

Country Link
US (1) US6169083B1 (pt)
EP (1) EP0938900B1 (pt)
JP (1) JP3877807B2 (pt)
KR (1) KR20000022204A (pt)
AT (1) ATE326232T1 (pt)
AU (1) AU713337B2 (pt)
DE (1) DE69735892T2 (pt)
DK (1) DK0938900T3 (pt)
ES (1) ES2264166T3 (pt)
PT (1) PT938900E (pt)
WO (1) WO1998001146A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010025027A1 (en) * 2000-03-07 2001-09-27 Sonis Stephen T. Inhibition of ceramide for the prevention and treatment of oral mucositis induced by antineoplastic drugs or radiation
US20020150629A1 (en) * 2000-05-31 2002-10-17 Yasuhiro Nishimura Zinc-supplementary compositions for oral administration
TWI280136B (en) * 2003-05-30 2007-05-01 Lytone Enterprise Inc Composition containing dipeptide of histidine and alanine for reducing uric acid
JP5390767B2 (ja) * 2005-03-11 2014-01-15 豊彦 宅重 細菌性口腔内疾患の治療用組成物、洗浄用処理液、止血用処理液、及び、細菌性口腔内疾患の治療方法
JP5205618B2 (ja) * 2007-06-19 2013-06-05 学校法人日本大学 抗菌剤
JP2009235053A (ja) * 2008-03-05 2009-10-15 Kyowa Chem Ind Co Ltd 口内炎予防乃至治療薬
WO2016057910A1 (en) * 2014-10-09 2016-04-14 Di Rocco Richard J +l-carnosine zinc formulations and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028921A (ja) * 1983-07-27 1985-02-14 Kaneshiro Nagai 炎症治癒促進剤
JPS61186322A (ja) * 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
JPS6314728A (ja) * 1986-07-03 1988-01-21 Zeria Shinyaku Kogyo Kk 肝障害の予防、治療剤
JPS63229058A (ja) * 1987-03-17 1988-09-22 大鳥 泰雅 骨形成材料の製法
JPH07116160B2 (ja) * 1987-08-10 1995-12-13 浜理薬品工業株式会社 結晶性l−カルノシン亜鉛錯体およびその製造法
DE69231576T2 (de) * 1991-09-09 2001-06-13 Kings College London, London Verwendung von Peptiden ZUR BEHANDLUNG VON KOMPLIKATIONEN UND PATHOLOGY BEI DIABETES
US5380530A (en) 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
FR2701948B1 (fr) * 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
AUPN784796A0 (en) * 1996-02-02 1996-02-22 Bellara Medical Products Limited Supplementation of glucocorticoids

Also Published As

Publication number Publication date
JP3877807B2 (ja) 2007-02-07
JPH1017490A (ja) 1998-01-20
US6169083B1 (en) 2001-01-02
EP0938900A1 (en) 1999-09-01
AU3274597A (en) 1998-02-02
KR20000022204A (ko) 2000-04-25
DK0938900T3 (da) 2006-09-04
EP0938900A4 (en) 2004-03-31
ATE326232T1 (de) 2006-06-15
WO1998001146A1 (fr) 1998-01-15
DE69735892D1 (de) 2006-06-22
DE69735892T2 (de) 2006-09-28
ES2264166T3 (es) 2006-12-16
EP0938900B1 (en) 2006-05-17
AU713337B2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
IL100942A0 (en) 2,4-diaminoquinazoline derivatives for enhancing antitumor activity
DK65293A (da) Fremgangsmåde til administrering af taxol
TR200003879T2 (tr) İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@
BR0207378A (pt) Tratamento de câncer
DE69027057D1 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
PT938900E (pt) Profilaticos/medicamentos para estomatite
NO880908L (no) Kombinasjonsterapi med bruk av antitumor immunotoksiner med tumornekrosefaktor.
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
FI934565A0 (fi) Pyrimidinderivat foer att oeka antitumoeraktiviteten
ATE285247T1 (de) Krebstherapie mit lymphotoxin
UY26431A1 (es) Quimioterapia de combinación
NO953349L (no) Kombinasjonsterapi av human cancer med cisplatin/tamoxifen
MD798G2 (ro) Metoda de tratament a cancerului mamar
CA2259997A1 (en) Remedies and preventives for stomatitis
ZA83767B (en) Panthenol derivatives
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
EP0285906A3 (en) Active agent for combating tumours
JPS5721393A (en) Tin compound, manufacture and use as cancer treating drug
Rosberger The assessment and treatment of nausea and vomiting associated with cancer chemotherapy
ES2062517T3 (es) Quimioterapia local con 4-hidroperoxiciclofosfamida.
ES1021355Y (es) Articulo para la organizacion personal tipo agenda.
ATE99959T1 (de) Immunokonjugate fuer krebs-diagnose und -therapie.